Stock Analysis of Septerna, Inc. Common Stock (SEPN) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code SEPN
Close 29.58
Change 2.04 / 7.41 %
Volume 915694
Vol Change 613889 / 203.41 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bullish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Septerna, Inc. Common Stock


Highs/Lows of Septerna, Inc. Common Stock
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week25.4416.27 % 0.104 % 30.5025.4019-Dec-2517-Dec-25
Two Week26.7610.54 % 0.523 % 30.5024.6319-Dec-2510-Dec-25
One Month23.1028.05 % 2.90 % 30.5023.3119-Dec-2520-Nov-25
Three Month15.7088.41 % 2.55 % 30.5015.4119-Dec-2522-Sep-25
Six Months10.49181.98 % 14.27 % 30.509.9619-Dec-2520-Jun-25
One year23.4026.41 % 16.49 % 30.504.1719-Dec-2518-Feb-25


Technical View of Septerna, Inc. Common Stock






Charts of Septerna, Inc. Common Stock


Returns of Septerna, Inc. Common Stock with Peers
Period / StockSEPNAHCOPNTAMLX
1 Week16.27%-4.13%0.402%-8.24%
1 Mth28.05%9.56%-9.16%-16.06%
3 Mth88.41%12.15%83.28%-9.69%
6mth181.98%17.57%37.67%135.69%
1 Year26.41%2.89%81.69%203.54%
2 Year-27.01%126.45%-14.02%
5 Years--73.25%--
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Septerna, Inc. Common Stock with Peers
Ratio / StockSEPNAHCOPNTAMLX
PE-20.8816.530.0159-6.85
P/B4.100.8610.01364.81
ROA-14.091.8672.51-61.11
ROE-19.615.2185.82-70.27
Debt To Equity0.00441.2900.0092
Revenue1075.00 K
611.92 %
3260.97 M
5.87 %
226579 M
%
87371.00 K
70.30 %
Net Income-71798.00 K
1817.66 %
90422.00 K
121.18 %
98293.21 M
214234 %
-301743.00 K
16534.80 %


Technicals of Septerna, Inc. Common Stock with Peers
Technical / StockSEPNAHCOPNTAMLX-
ADX37.9139.7132.8519.81
CMF0.136-0.130-0.135-0.310
MFI57.8136.2427.3745.24
RSI66.5753.3935.3834.68
MACD Abv SignalTrueTrueFalseFalse
Price Above 50 MATrueTrueFalseFalse-
Price Above 200 MATrueTrueTrueTrue-


About : Septerna, Inc. Common Stock


Address : 250 East Grand Avenue, South San Francisco, CA, United States, 94080
Tel : 650 338 3533
URL : https://septerna.com
Code : SEPN, ISIN : US81734D1046, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 25_Oct_2024
Employee Count : 75

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. The company also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders, including obesity and type 2 diabetes. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)